Oxiracetam prevents the MK-801 induced amnesia for the elevated plus-maze in mice

Behavioural Brain Research

Volumn 117, Issue 1-2, 2000, Pages 147-151

  Hliák, Zdeněk ^a   Krejčí, Ivan ^b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b Research Institute of Pharmacy and Biochemistry Prague   (Czech Republic)

Author keywords

Elevated plus maze; Learning; Memory; Mice; MK 801; Oxiracetam

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NOOTROPIC AGENT; OXIRACETAM;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; LATENT PERIOD; LEARNING; LONG TERM MEMORY; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPATIAL ORIENTATION;

EID: 0034694950     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00298-9     Document Type: Article

References (37)

1. Aniracetam restores object recognition impaired by age, scopolamine and nucleus basalis lesions
2. Oxiracetam prevents the hippocampal cholinergic hypofunction induced by receptor NMDA blocker AP7
3. Amnesic effect of the novel anti-convulsant MK-801
4. A synaptic model of memory: Long-term potentiation in the hippocampus
5. A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task
6. Relationships between arousal and cognition-enhancing effects of oxiracetam
7. The topography of MK-801-induced locomotor patterns in rats
8. Effects of excitatory amino acid antagonists on social recognition of male rats
9. Concurrent administration of subeffective doses of scopolamine and MK-801 produces a short-term amnesia for the elevated plus-maze in mice
10. Effect of alaptide, its analogues and oxiracetam on memory for an elevated plus-maze in mice
11. Utility of an elevated plus-maze for the evaluation of memory in mice: Effects of nootropics, scopolamine and electroconvulsive shock
12. Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice
13. Long-term potentiation and the mechanisms of memory
14. Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats
15. The use a plus-maze to measure anxiety in the mouse
16. Enhancement of contextual fear-conditioning by putative (±)-alpha-amino-3-hydroxy-5-methylisoxale-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice
17. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze
18. PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice
19. Retrograde messengers, long-term potentiation and memory
20. Ameliorating effects of histidine on learning deficits in an elevated plus-maze test in mice and the contribution of cholinergic neuronal systems
21. Ameliorating effects of histidine on scopolamine-induced learning deficits using an elevated plus-maze test in mice
22. Comparison of glutamate antagonists in continuous multiple-trial and single-trial dark avoidance
23. The pharmacology of the nootropics new insights and new questions
24. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist AP-5
25. Excitatory amino acids and neuronal plasticity: Modulation of AMPA receptors as a novel substrate for the action of nootropic drugs
26. Oxiracetam and D-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by N-methyl-D-aspartate receptor antagonist 2-amino-5-phosphonovalerate
27. Validation of open: Closed arms entries in an elevated plus-maze as a measure of anxiety in the rat
28. Effect of oxiracetam on scopolamine-induced amnesia in the rat in a spatial learning task
29. Effects of phencyclidine-like drugs on punished behavior in rats
30. Effect of the cognition enhancing agent oxiracetam on electrical activity of hippocampal slices
31. Behavioral effects of MK-801 mimic deficits associated with hippocampal damage
32. Resistance of experimentally-induced changes in murine plus-maze behaviour to altered retest conditions
33. Improvement of avoidance acquisition by the nootropic drug oxiracetam in mice
34. Aniracetam augments, and midazolam inhibits, the long-term potentiation in guinea-pig hippocampal slices
35. The behavioural effects of MK-801: A comparison with antagonists acting non-competitively and competitively at the NMDA receptor
36. Immediate and long-lasting effects of MK-801 on motor activity spatial navigation in a swimming pool and EEG in the rat
37. Behavioral effects of MK-801 in the rat